ROCK1 and Alzheimer disease: We showed that ROCK1 is deposited with highly aggregated Aβ in human brain tissue, and that activated ROCK1 inhibits autophagic Aβ clearance via interaction with Beclin1, increasing Aβ burden during AD progression.